As science adviser of Operation Warp Speed, the veteran pharmaceutical executive helped usher a coronavirus vaccine to the US market in record time.
Author: Karen Weintraub, USA TODAY
Moderna becomes second company to request emergency FDA authorization for COVID-19 vaccine candidate
Moderna will be the second coronavirus vaccine maker to request authorization from the government after similarly positive trial results for Pfizer.
Why this Harvard doctor is optimistic about US overcoming COVID-19 despite ‘epidemic of mistrust’
Paul Farmer has seen the effect of Haiti’s earthquake, Rwanda’s genocide and West Africa’s Ebola outbreak. They show how the US could handle COVID.
Pfizer and Moderna use mRNA in their COVID-19 vaccines. This never-before-used technology could transform how science fights diseases.
Though messenger RNA technology like Pfizer, Moderna use hasn’t grabbed headlines before now, some researchers have been working on it for decades.
When will COVID-19 go away? There may be a vaccine by the end of the year, but ‘normality’ may not be reality until the end of 2021
Hold onto your masks. A vaccine may be possible by the end of the year, but life won’t return to what it was like in the beforetimes anytime soon.
Pfizer’s COVID-19 vaccine candidate shown to be 90% effective in early findings
Pfizer is the first drug company to release data from a large, Phase 3 trial, designed to show both effectiveness and safety.
Black Americans are the most hesitant to get a COVID-19 vaccine
Attracting Black Americans to join COVID-19 vaccine trials is tough. Getting them to take an approved one may be harder, polls show.
COVID-19 vaccine should be ready for most vulnerable late this year, for everyone by spring, HHS Secretary Alex Azar says
During a rare CDC public briefing, HHS Secretary Alex Azar on Wednesday outlined a timeline for the COVID-19 vaccine and pledged it would be safe.
Pfizer reports ‘potential’ with COVID-19 candidate vaccine after expanding trial to 44,000 people
Pfizer expects to have data next month on how well its COVID-19 candidate vaccine is protecting people against the coronavirus.
Behind the scenes at the Metropolitan Museum of Art: What does it take reopen a national landmark?
New York City’s famed Metropolitan Museum of Art will welcome guests again after COVID caused it’s longest shutdown in history. What does that take?